Drug metabolites are created when a drug is metabolized into a different form that still has therapeutic effects. Active metabolites can be produced by drug metabolism redox reactions like heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations. In some rare circumstances, conjugation reactions can also produce an active metabolite.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V72291 | Captopril EP Impurity C (3-Mercaptoisobutyric acid; 3-Mercaptoisobutyric acid) | 26473-47-2 | Captopril EP Impurity C is an impurity of Captopril. |
|
V72283 | Captopril EP Impurity D (3-Bromoisobutyric acid) | 56970-78-6 | Captopril EP Impurity D is an impurity of Captopril. |
|
V72292 | Captopril EP Impurity E (Captopril EP Impurity E) | 23500-15-4 | Captopril EP Impurity E is an impurity of Captopril. |
|
V72286 | Captopril EP Impurity J (S-Acetylcaptopril) | 64838-55-7 | Captopril EP Impurity J is an impurity of Captopril. |
|
V72159 | Carboxy Gliclazide-d4 | 1346602-90-1 | Carboxy Gliclazide-d4 is deuterated labeled Carboxy Gliclazide. |
|
V72271 | Cetirizine 3-chloro impurity | 1232460-31-9 | Cetirizine 3-chloro impurity is an impurity in Cetirizine 3-chloro. |
|
V72164 | Cetirizine Impurity B dihydrochloride (Cetirizine EP Impurity 04) | 1000690-91-4 | Cetirizine Impurity B di-HCl is an impurity of Cetirizine di-HCl. |
|
V37799 | Cinacalcet metabolite M4 | 104774-87-0 | Cinacalcet metabolite M4 is a metabolite of Cinacalcet (AMG-073; KRN-1493; Regpara; Sensipar; Mimpara), which isallosteric agonist of Ca receptor (CaR)approved as a medication for the treatment of hyperparathyroidism, parathyroid carcinoma, and primary hyperparathyroidism. |
|
V72278 | Cirsiliol 4′-glucoside | 41087-98-3 | Cirsiliol 4′-glucoside is a free radical scavenger discovered from Ruellia tuberosa L. |
|
V72192 | Clocortolone pivalate | 34097-16-0 | Clocortolone pivalate is a synthetic glucocorticoid corticosteroid and corticosteroid ester. |
|
V72183 | cPrPMEDAP | 182798-83-0 | cPrPMEDAP is an intermediate metabolite of GS-9219. |
|
V72262 | Cyclo(Tyr-Val) (Cyclo(L-Tyr-L-Val)) | 21754-25-6 | Cyclo(Tyr-Val) (Cyclo(L-Tyr-L-Val)) is a diketopiperazine secondary fungal metabolite originally extracted from N. |
|
V84230 | Cyclobenzaprine N-oxide (Cyclobenzaprine N-oxide impurity 5; Cyclobenzaprine N-oxide) | 6682-26-4 | |
|
V72240 | Daclatasvir Impurity B | 2226541-13-3 | Daclatasvir Impurity B is an impurity in Daclatasvir. |
|
V72265 | Daclatasvir Impurity C | 1256385-55-3 | Daclatasvir Impurity C is an impurity in daclatasvir. |
|
V72233 | Daidzein 4'-β-D-glucuronide | 264236-77-3 | Daidzein 4'-β-D-glucuronide (Compound M4) is a metabolite of Daidzein. |
|
V37601 | Dasatinib N-oxide | 910297-52-8 | Dasatinib N-oxide is a major and N-oxidated metabolite of Dasatinib (BMS354825; Sprycel), whichis an approved anticancer drug acting as a dual Bcr-Abl and Src kinase inhibitor. |
|
V72250 | Dasatinib N-oxide-d8 (Dasatinib N-oxide-d8) | 1189988-36-0 | Dasatinib N-oxide-d8 is the deuterated form of Dasatinib N-oxide. |
|
V2223 | DCBA | 72236-23-8 | DCBA (DEET ω-Carboxylic Acid) is ametaboliteof insect repellent N-N-diethyl-meta-toluamide (DEET). |
|
V79316 | DDC 3′-O-β-D glucuronide | DDC 3′-O-β-D glucuronide (compound 5) is a drug metabolite that prevents fibrosis and oligomerization of Aβ42. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
